Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 15, 2014
A cytokine-delivering polymer is effective in reducing tumor burden in a head and neck squamous cell carcinoma murine modelYuan Lin, Jie Luo, Weichao Eric Zhu, et al.
Nature Biotechnology|April 13, 2004
Adipose-derived adult stromal cells heal critical-size mouse calvarial defectsCatherine M Cowan, Yun-Ying Shi, Oliver O Aalami, et al.
Clinical Breast Cancer|November 14, 2018
Phase 1b Study of Trebananib Plus Paclitaxel and Trastuzumab in Patients With HER2-Positive Locally Recurrent or Metastatic Breast CancerPeter A Kaufman, Hans Wildiers, Gilles Freyer, et al.
ACS Applied Materials & Interfaces|April 18, 2018
Using an Engineered Galvanic Redox System to Generate Positive Surface Potentials that Promote Osteogenic FunctionsYulong Zhang, Zhong Zheng, Mengliu Yu, et al.
Cancer Chemotherapy and Pharmacology|September 23, 2019
Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing settingKari M Morrissey, Mathilde Marchand, Hina Patel, et al.
Biomaterials|July 15, 2022
Genetic and pharmacologic suppression of PPARγ enhances NELL-1-stimulated bone regenerationJustine Tanjaya, Pin Ha, Yulong Zhang, et al.
Lab on a Chip|September 22, 2005
Detection of picomolar levels of interleukin-8 in human saliva by SPRChu-Ya Yang, Evan Brooks, Yang Li, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 5, 2025
Population Pharmacokinetics and Exposure-Response of Subcutaneous Atezolizumab in Patients With Non-Small Cell Lung CancerPhyllis Chan, Stephanie N Liu, Nathalie Gosselin, et al.
Advances in Therapy|February 2, 2026
Efficacy and Safety of Oral Treprostinil in Patients with Pulmonary Arterial Hypertension on Background Monotherapy or Dual TherapyDaniel Lachant, Amresh Raina, Mrinalini Krishnan, et al.
Frontiers in Pharmacology|October 13, 2022
Development of a pediatric physiologically-based pharmacokinetic model to support recommended dosing of atezolizumab in children with solid tumorsWeize Huang, Felix Stader, Phyllis Chan, et al.
Pageof 15